Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,630 total articles

Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company

Precision Optics Announces Receipt of $1.3 Million Follow-On Production Orders from Large Defense Company

Precision Optics Corporation announced receipt of $1.3 million in follow-on production orders from a large U.S. defense contractor for advanced optical assemblies. The program, in production since 2018, could continue for at least ten years with upcoming negotiations for a long-term manufacturing agreement aimed at improving production continuity a…

WidePoint to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 2:30pmET

WidePoint to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Tuesday, September 15, 2026, at 2:30pmET

WidePoint Corporation, a US-based managed solution provider specializing in secure mobility management, will present an overview of its business at the H.C. Wainwright 28th Annual Global Investment Conference on September 15, 2026. The company highlights its expertise in identity and access management, mobility managed services, cloud security, and…

Barletta Boats unveils model year 2027 lineup with design refinements, new technology and innovative features

Barletta Boats unveils model year 2027 lineup with design refinements, new technology and innovative features

Barletta Boats, a wholly owned subsidiary of Winnebago Industries, has unveiled its 2027 model year lineup with comprehensive updates across all product series. Enhancements include redesigned interiors, expanded power options, advanced digital helm technology, and upgraded boarding features. New products like the upcoming Halcyon series aim to exp…

Concentrix Named a Leader in Customer Experience Management as AI Orchestration Defines the Industry’s Future

Concentrix Named a Leader in Customer Experience Management as AI Orchestration Defines the Industry’s Future

Concentrix Corporation has been named a Leader in the Everest Group's Customer Experience Management (CXM) Services PEAK Matrix 2026, standing out for its vision and execution across Americas, APAC, and EMEA. The recognition reflects Concentrix's expertise in integrating AI and human operations to deliver measurable business outcomes, including sig…

Fortrea to Participate in September Investor Conferences

Fortrea to Participate in September Investor Conferences

Fortrea, a Nasdaq-listed global contract research organization, announced that its top executives will participate in three major healthcare and pharmaceutical investor conferences in September 2026. The events include the Baird Global Healthcare Conference, Deutsche Bank Healthcare Summit, and RBC Pharma Services and Life Science Tools Virtual Con…

LPL Financial Welcomes Northstar Financial Advisors, LLC

LPL Financial Welcomes Northstar Financial Advisors, LLC

LPL Financial announced that Jeneen Slack, founder of Northstar Financial Advisors, has joined LPL’s broker-dealer and Registered Investment Advisor platform, bringing over $270 million in client assets. Slack's team, known for personalized, relationship-focused financial advice, chose LPL for its innovative technology and support infrastructure to…

Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder

Optimi Health Corp. announced plans to initiate a Health Canada-authorized Phase 2 clinical trial evaluating the safety and efficacy of a single supervised dose of natural psilocybin for treating major depressive disorder (MDD). The multisite trial will involve up to 200 participants across Canada, with dosing expected to complete by the end of 202…

Birchtech to Participate in Upcoming Investor Conferences

Birchtech to Participate in Upcoming Investor Conferences

Birchtech Corp., a leader in specialty activated carbon technologies for air and water purification, announced management's participation in the Lake Street Capital Markets 10th Annual Best Ideas Growth Conference and the H.C. Wainwright 28th Annual Global Investment Conference. The company's CEO will engage with institutional investors and deliver…

Private Markets and AI Emerge as Defining Priorities for Asset Managers as Regional Priorities Shape Growth Strategies

Private Markets and AI Emerge as Defining Priorities for Asset Managers as Regional Priorities Shape Growth Strategies

Nasdaq's 2026 Global Voice of the Issuer Study reveals private markets lead client demand globally across all regions, with 80% of asset managers using AI in product development though only 26% use it broadly across stages. Despite identifying growth areas, firms face difficulties scaling new products due to a crowded market and distribution challe…

ZenaTech Secures Irish Aviation Authority Operational Authorization for Drone-Based Crop and Soil Nutrient Application Services

ZenaTech Secures Irish Aviation Authority Operational Authorization for Drone-Based Crop and Soil Nutrient Application Services

ZenaTech, Inc., a Nasdaq-listed AI drone and Drone as a Service (DaaS) company, announced that its subsidiary ZenaDrone received Specific Operations Risk Assessment (SORA) approval from the Irish Aviation Authority. This authorization permits large-scale drone-based application of fertilizers and soil nutrients on Irish farmland, marking a signific…

Mint’s Majority Owned Subsidiary Rice Robotics Hong Kong Enters into Non-Exclusive Framework Cooperation Agreement with Vengine to Scale Manufacturing Network

Mint’s Majority Owned Subsidiary Rice Robotics Hong Kong Enters into Non-Exclusive Framework Cooperation Agreement with Vengine to Scale Manufacturing Network

Mint Incorporation Limited (NASDAQ: MIMI) announced that its majority-owned subsidiary Rice Robotics Hong Kong entered into a non-exclusive Framework Cooperation Agreement with Vengine. The agreement aims to explore collaboration in product development, manufacturing support, and distribution to scale mass production and expand market reach in Asia…

Leonardo DRS Awarded $96 Million in Contracts to Provide Critical MK 41 Vertical Launching System Electronics Hardware

Leonardo DRS Awarded $96 Million in Contracts to Provide Critical MK 41 Vertical Launching System Electronics Hardware

Leonardo DRS has been awarded contracts totaling $96 million to provide advanced electronics hardware for the U.S. Navy's MK 41 Vertical Launching System, a widely deployed naval missile launching system used by the U.S. and allied navies. The company will supply Programmable Power Supplies, Launch Control Units, and Transformer Platforms essential…

Snail Games to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, at 4:00 p.m. ET

Snail Games to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, at 4:00 p.m. ET

Snail, Inc., a Nasdaq-listed global developer and publisher of interactive digital entertainment, announced its scheduled presentation and one-on-one meetings at the H.C. Wainwright 28th Annual Global Investment Conference held September 14-16, 2026 in New York City. Management will present on September 14 at 4:00 p.m. ET, with the presentation ava…

NextNRG Announces 1-for-10 Reverse Stock Split

NextNRG Announces 1-for-10 Reverse Stock Split

NextNRG, Inc., an AI-driven energy innovation company listed on Nasdaq under the ticker NXXT, announced a 1-for-10 reverse stock split effective September 14, 2026. This action will reduce the outstanding shares from approximately 168.4 million to 16.8 million, aiming to consolidate the share structure without impacting overall company value. The c…

BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference

BioCardia to Present CardiAMP Regulatory and Corporate Progress at H.C. Wainwright 28th Annual Global Investment Conference

BioCardia, Inc. announced that CEO Dr. Peter Altman will present at the H.C. Wainwright 28th Annual Global Investment Conference, highlighting advancements in CardiAMP autologous cell therapy regulatory submissions in Japan and the US, the ongoing CardiAMP HF II pivotal trial, and developments in their Helix delivery and Heart3D imaging platforms. …

Stifel Deepens Fixed Income Platform with Senior Talent

Stifel Deepens Fixed Income Platform with Senior Talent

Stifel Financial Corp. appointed Conor Daly and Jim Franz as Co-Heads of Leveraged Finance Sales in Europe, enhancing its global Fixed Income platform. The hires bring extensive experience and established investor relationships, aligning with Stifel's strategy to expand its Fixed Income business in Europe and provide comprehensive financing solutio…

Vistagen to Present at Psych Congress 2026

Vistagen to Present at Psych Congress 2026

Vistagen, a Nasdaq-listed biopharmaceutical company, announced it will present encouraging efficacy data from its Phase 3 trials of fasedienol nasal spray for very severe social anxiety disorder at Psych Congress 2026. The intranasal product aims to offer rapid therapeutic benefits via a novel pherine mechanism targeting nose-to-brain neurocircuitr…

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

Quoin Pharmaceuticals Releases New NETHERTON NOW Video: Aminah’s Story Featuring Laura Wright-Sexton, MD, the Physician Who First Met Her Daughter in the ICU

Quoin Pharmaceuticals released a new NETHERTON NOW video featuring the story of Aminah, a young patient with Netherton Syndrome and her adoptive mother who is also a physician. The video aims to raise awareness about this rare disease. Quoin's lead drug candidate, QRX003, is currently in late-stage Phase 2/3 clinical trials with positive interim da…